Shire P.L.C. has accused Mylan Inc. of infringing on its patent for Fosrenol, a drug that treats kidney failure.
Copyright PHILY - Philly.com
Shire P.L.C. has accused Mylan Inc. of infringing on its patent for Fosrenol, a drug that treats kidney failure.